Myovant Sciences Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Myovant Sciences Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $90.70 million as of 2021-03-31, per its 10-K filed 2021-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2021-05-11
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $90.70M.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $4.15M.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $50.88M.
- 2018-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $40.56M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2021-03-31 | $90.70M 10-K · filed 2021-05-11 | |
| 2020-03-31 | $4.15M 10-K · filed 2021-05-11 | |
| 2019-03-31 | $50.88M 10-K · filed 2020-05-18 | |
| 2018-03-31 | $40.56M 10-K · filed 2020-05-18 | |
| 2017-03-31 | $10.26M 10-K · filed 2020-05-18 | $10.26M 10-K · filed 2017-06-14 |
| 2016-03-31 | $0.00 10-K · filed 2019-05-24 |